New hope for tough pancreatic cancer: experimental combo enters key trial
NCT ID NCT06492915
Summary
This study is testing a new three-drug combination for people with advanced pancreatic cancer that cannot be surgically removed. It combines an experimental pill called Chiauranib with two standard chemotherapy drugs. The goal is to see if this combination can better control the cancer's growth and spread, and to understand its safety for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.